Bacterial antigen-induced release of white cell- and platelet-derived bioactive substances in vitro

International Journal of Gastrointestinal Cancer

Volumn 31, Issue 1-3, 2002, Pages 165-179

  Hammer, Janne H ^a   Mynster, Tommie ^a   Rosendahl, Solveig ^b   Reimert, Claus M ^c   Brünner, Nils ^d   Skov, Flemming ^b   Nielsen, Hans J ^a,e  

^a Mental Health Center Glostrup   (Denmark)

^b NYKØBING FALSTER HOSPITAL   (Denmark)

^c DANISH BILHARZIASIS LABORATORY   (Denmark)

^d FINSEN LABORATORY   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Blood transfusion; Cancer; E. coli, LPS; ECP; Histamine; Leukofiltration; MPO; PAI 1; Postoperative infectious complications; Protein A; Staphylococcus aureus

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; STAPHYLOCOCCUS PROTEIN A;

ARTICLE; BLOOD DONOR; BLOOD STORAGE; BLOOD TRANSFUSION; CANCER GROWTH; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FILTRATION; HUMAN; LEUKOCYTE; NORMAL HUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; SUPERNATANT; THROMBOCYTE;

EID: 0036934553     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:31:1-3:165     Document Type: Article

References (39)

1. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997;24:34-40.
2. Nielsen HJ. Clinical impact of bioactive substances in blood components: Implications for leukocyte filtration. Infus Ther Transfus Med 1998;25:296-304.
3. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001;97:1180-1195.
4. Edna TH, Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer. Eur J Surg 1998;164:449-456.
5. Chang H, Hall GA, Geerts WH, et al. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vax Sang 2000;78:13-18.
6. Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Scand J Gastroenterol 2000;35:212-219.
7. Grandis JR, Snyderman CH, Johnson JT, et al. Postoperative wound infection. A poor prognostic sign for patients with head and neck cancer. Cancer 1992;70:69-73.
8. Swisher SG, Holmes EC, Hunt KK, et al. Perioperative blood transfusions and decreased long-term survival in oesophageal cancer. J Thorac Cardiovasc Surg 1996;112:341-348.
9. Mynster T, Christensen IJ, Moesgaard F, et al. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after colorectal cancer surgery. Br J Surg 2000;87:1553-1562.
10. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996;101:299-308.
11. Blajchman MA, Dzik S, Vamvakas EC, et al. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev 2001;15:108-135.
12. Nielsen HJ, Edvardsen L, Vangsgaard K, et al. Time-dependent histamine release from stored human blood products. Br J Surg 1996;83:257-262.
13. Nielsen HJ, Reimert CM, Pedersen AN, et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996;36:960-965.
14. Nielsen HJ, Werther K, Mysnter T, et al. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999;39:1078-1083.
15. Mynster T, Dybkjaer E, Kronborg G, et al. Immunomodulation by blood transfusion: is storage time important? Vox Sang 1998;74:176-181.
16. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999;39:701-710.
17. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999;178:570-572.
18. Nielsen HJ, Werther K, Mynster T, et al. Bacteria-induced release of white cell- and platelet-derived vascular endothelial growth factor in vitro. Vox Sang 2001;80:170-178.
19. Mynster T, Hammer JH, Nielsen HJ. Prestorage and bedside leukofiltration of whole blood modulates storage time-dependent suppression of in vitro TNFα release. Br J Haematol 1999;106:248-251.
20. Effersoe H, Espersen F, Andersen V. Induction of immunoglobulin secretion in cultured human lymphocytes by 4 Staphylococcus aureus strains and their extracts. APMIS 1984;92:121-128.
21. Nielsen HJ, Rosendahl S, Sigvard S, et al. Storage time-dependent changes in the relative white cell-derived substance content in buffy-coat-depleted SAGM blood. Transfusion 2000;40:69S-70S.
22. Reimert CM, Venge P, Kharazmi A, et al. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immunosorbent assay. J Immunol Methods 1991;138:285-290.
23. Fredens K, Dybdahl H, Dahl R, et al. Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS 1988;96:711-719.
24. Kaufman LE. The expanding clinical spectrum of multi-system disease associated with eosinophilia. Arch Dermatol 1997;133:225-227.
25. Kurose I, Granger DN. Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann N Y Acad Sci 1994;723:158-179.
26. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-3521.
27. Cerutti PA. Oxy-radicals and cancer. Lancet 1994;344:862-863.
28. Qureshi A, Gorey TF, Byrne P, et al. Oxygen free radical activity in experimental colonic carcinoma. Br J Surg 1994;81:1058-1059.
29. Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995;42:162-174.
30. Watson SA, Wilkinson LJ, Robertson JRF, et al. Effect of histamine on growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993;34:1091-1096.
31. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994;35:1632-1636.
32. Van Goor H, de Graaf JS, Grond J, et al. Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. Br J Surg 1994;81:1046-1049.
33. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 2000;32:78-84.
34. Pappot H, Gardsvoll H, Romer J, et al. Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler 1995;376:259-267.
35. Bajou K, Noel A, Gerard RD, et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 1998;4:923-928.
36. Mynster T, Nielsen HJ. Storage tiem of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 2001;44:955-964.
37. Pedersen AN, Brunner N, Hoeyer-Hansen G, et al. Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients. Clin Chemistry 1999;45:1206-1213.
38. Nordenbaek C, Johansen JS, Junker P, et al. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalisation. J Infect Dis 1999;180:1722-1726.
39. Ratjen F, Havers W, Braun J. Intrapulmonary protein leakage in immunocompromised children and adults with pneumonia. Thorax 1999;54:432-436.